ApprovalTrail

Approval · Notice of Compliance 2664 · 1998

PROLEUKIN: Notice of Compliance 2664

Issued November 6, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2664
Date
November 6, 1998
Product type
Biologic
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Change in batch size and changes in product testing
Therapeutic class
Immunomodulating agent

Products in this notice

BrandDINStatus today
PROLEUKINNot yet assigned—

Medicinal ingredients